首页> 外国专利> -1 AGP501 RCA-HRP Kit for liver cirrhosis or liver cancer specific diagnosis comprising monoclonal antibody AGP501 against asialo -1 acid glycoprotein and RCA-HRP conjugates and uses thereof

-1 AGP501 RCA-HRP Kit for liver cirrhosis or liver cancer specific diagnosis comprising monoclonal antibody AGP501 against asialo -1 acid glycoprotein and RCA-HRP conjugates and uses thereof

机译:-1 AGP501 RCA-HRP试剂盒,用于抗肝硬化或肝癌的特异性诊断,包括抗唾液酸-1酸性糖蛋白和RCA-HRP缀合物的单克隆抗体AGP501及其用途

摘要

The present invention relates to a kit for cirrhosis or liver cancer specific diagnosis including a monoclonal antibody AGP501 against α-1 acid glycoprotein and an RCA II-HRP conjugate and a use thereof. The present invention facilitates early discovery and treatment of cirrhosis or liver cancer by accurate diagnosis of cirrhosis and liver cancer. Currently, in vitro diagnostic reagents for diagnosing cirrhosis in an early stage using blood do not exit. AFP is used for liver cancer diagnosis, but development of a new diagnosis reagent is needed due to a very low positive rate for liver cancer. A specialized diagnosis kit AsAGP for cirrhosis or liver cancer using a technique of the present invention will contribute to development of medical instrument industries and diagnostic medicine by being widely supplied to domestic and foreign specialty medical institutions by commercialization of the diagnostic kit.
机译:本发明涉及用于肝硬化或肝癌特异性诊断的试剂盒,其包含针对α-1酸性糖蛋白的单克隆抗体AGP501和RCA II-HRP缀合物及其用途。本发明通过准确诊断肝硬化和肝癌而促进肝硬化或肝癌的早期发现和治疗。目前,在早期使用血液诊断肝硬化的体外诊断试剂还不存在。 AFP用于肝癌诊断,但是由于肝癌的阳性率非常低,因此需要开发一种新的诊断试剂。使用本发明的技术的用于肝硬化或肝癌的专用诊断试剂盒AsAGP将通过诊断试剂盒的商业化而广泛地提供给国内外专业医疗机构,从而有助于医疗器械行业和诊断医学的发展。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号